asthma
Conditions
Interventions
Gold Standard:Lung function increase in FEV1 by >200ml and >12% from baseline after 4 weeks treatment.
was 
using 
Spirometric 
Sponsors
Shanghai General Hospital
Eligibility
Sex/Gender
All
Age
16 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. aged 16-65 years; 2. recurrent symptoms of dyspnea, cough, wheeze, or chest tightness of at least eight weeks duration.
Exclusion criteria
Exclusion criteria: 1. respiratory infection in the latest 2 mouths; 2. Patients with bronchiectasis, pulmonary fibrosis, history of thoracic and pulmonary surgery and other pulmonary diseases; 3. more than 10 pack-year smoking; 4. Recent use of glucocorticoids, bronchodilators and other drugs patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| bronchodilator reversibility test;FENO;IOS; | — |
Countries
China
Contacts
Public ContactMin Zhang
Shanghai General Hospital
Outcome results
None listed